Edwards Lifesciences Corp (EW) Shareholder Ledyard National Bank Decreased Its Stake as Shares Rose

Edwards Lifesciences Corporation (NYSE:EW) Corporate Logo

In Edwards Lifesciences Corp (EW) was reduced the stake owned by Ledyard National Bank. The decrease is 67.03% according to 2018Q3 SEC filling. By selling 35,419 shares Ledyard National Bank made the stock popped up with 13.75%. The institutional investor is holding 17,419 shares, compared to the 52,838 from the previous quarter. And the announced value of the industrial specialties company is $3.03M for the 2018Q3. Edwards Lifesciences Corp has $31.67 billion market cap. The stock decreased 0.85% or $1.31 during the last trading session, reaching $151.49.Currently Edwards Lifesciences Corporation is uptrending after 37.86% change in last January 14, 2018. EW has also 58,670 shares volume. EW outperformed by 37.86% the S&P 500.

For a total of shares it increased its holding in by shares in the quarter, and has risen its stake in .

Edwards Lifesciences Corporation (NYSE:EW)’s earnings report is anticipated on February, 7., as reported by Faxor. Analysts expect change of 24.47 % or $0.23 from previous year’s $0.94 EPS compared to current’s $1.17 EPS. If $1.17 is reported, EW’s profit will reach $244.60 million for 32.37 P/E. Wall Street forecasts 9.35 % EPS growth as of February, 7.

There’s a significant Edwards Lifesciences Corporation (NYSE:EW) news published by 247Wallst.com. It’s an item titled: “Top Analyst Upgrades and Downgrades: Abbott Labs, Albermarle, Boston Scientific, BP, Embraer, Intuit, Marathon Oil, Norfolk Southern and More – 24/7 Wall St.” on December 18, 2018.

Edwards Lifesciences Corporation (NYSE:EW) Ratings Coverage

A total of 11 analysts rate Edwards Lifesciences (NYSE:EW) as follows: 5 “Buy”, 4 “Hold” and 2 “Sell”. Тherefore 45% are bullish. (NYSE:EW) has 14 ratings reports on Jan 14, 2019 according to StockzIntelligence. On Monday, October 29 Citigroup maintained Edwards Lifesciences Corporation (NYSE:EW) with “Sell” rating. On Thursday, October 11 Morgan Stanley maintained Edwards Lifesciences Corporation (NYSE:EW) with “Overweight” rating. On Tuesday, July 31 the firm has “Sell” rating by Citigroup given. On Thursday, December 6 Raymond James maintained the shares of EW in report with “Outperform” rating. The company rating was maintained by Citigroup on Wednesday, January 2. On Friday, July 27 the firm has “Neutral” rating by JP Morgan given. On Tuesday, October 2 the rating was downgraded by Guggenheim to “Neutral”. On Friday, July 27 the company was maintained by Wells Fargo. On Friday, December 7 the stock of Edwards Lifesciences Corporation (NYSE:EW) has “Overweight” rating given by Morgan Stanley. On Thursday, December 6 the firm has “Buy” rating given by Jefferies.

Edwards Lifesciences Corporation (NYSE:EW) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.